vs
Side-by-side financial comparison of DXC Technology Co (DXC) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.2B, roughly 1.7× DXC Technology Co). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 3.4%, a 4.6% gap on every dollar of revenue. On growth, Fresenius Medical Care AG posted the faster year-over-year revenue change (-0.3% vs -1.0%).
DXC Technology Company is an American multinational information technology (IT) services and consulting company headquartered in Ashburn, Virginia.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
DXC vs FMS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.2B | $5.5B |
| Net Profit | $107.0M | $434.2M |
| Gross Margin | — | 27.4% |
| Operating Margin | 8.2% | 11.7% |
| Net Margin | 3.4% | 7.9% |
| Revenue YoY | -1.0% | -0.3% |
| Net Profit YoY | 87.7% | 240.4% |
| EPS (diluted) | $0.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.2B | $5.5B | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.2B | $5.5B | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — | ||
| Q1 24 | $3.4B | — |
| Q4 25 | $107.0M | $434.2M | ||
| Q3 25 | $36.0M | — | ||
| Q2 25 | $16.0M | — | ||
| Q1 25 | $264.0M | — | ||
| Q4 24 | $57.0M | $127.6M | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $26.0M | — | ||
| Q1 24 | $-200.0M | — |
| Q4 25 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 8.2% | 11.7% | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 7.3% | — | ||
| Q4 24 | 8.9% | 5.1% | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 6.9% | — | ||
| Q1 24 | 8.2% | — |
| Q4 25 | 3.4% | 7.9% | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | -5.9% | — |
| Q4 25 | $0.61 | — | ||
| Q3 25 | $0.20 | — | ||
| Q2 25 | $0.09 | — | ||
| Q1 25 | $1.42 | — | ||
| Q4 24 | $0.31 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $0.14 | — | ||
| Q1 24 | $-1.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $1.7B |
| Total DebtLower is stronger | $3.1B | — |
| Stockholders' EquityBook value | $3.1B | $15.4B |
| Total Assets | $13.2B | $33.5B |
| Debt / EquityLower = less leverage | 0.98× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.6B | — | ||
| Q3 24 | $3.8B | — | ||
| Q2 24 | $3.8B | — | ||
| Q1 24 | $3.8B | — |
| Q4 25 | $3.1B | $15.4B | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.0B | $17.0B | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $2.9B | — | ||
| Q1 24 | $2.8B | — |
| Q4 25 | $13.2B | $33.5B | ||
| Q3 25 | $13.6B | — | ||
| Q2 25 | $13.4B | — | ||
| Q1 25 | $13.2B | — | ||
| Q4 24 | $13.0B | $36.3B | ||
| Q3 24 | $13.5B | — | ||
| Q2 24 | $13.4B | — | ||
| Q1 24 | $13.9B | — |
| Q4 25 | 0.98× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | 0.98× | — | ||
| Q1 25 | 0.93× | — | ||
| Q4 24 | 1.22× | — | ||
| Q3 24 | 1.28× | — | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | 1.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $414.0M | $2.9B |
| Free Cash FlowOCF − Capex | $359.0M | — |
| FCF MarginFCF / Revenue | 11.2% | — |
| Capex IntensityCapex / Revenue | 1.7% | — |
| Cash ConversionOCF / Net Profit | 3.87× | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | $1.1B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $414.0M | $2.9B | ||
| Q3 25 | $409.0M | — | ||
| Q2 25 | $186.0M | — | ||
| Q1 25 | $315.0M | — | ||
| Q4 24 | $650.0M | $2.6B | ||
| Q3 24 | $195.0M | — | ||
| Q2 24 | $238.0M | — | ||
| Q1 24 | $280.0M | — |
| Q4 25 | $359.0M | — | ||
| Q3 25 | $365.0M | — | ||
| Q2 25 | $143.0M | — | ||
| Q1 25 | $238.0M | — | ||
| Q4 24 | $568.0M | — | ||
| Q3 24 | $154.0M | — | ||
| Q2 24 | $190.0M | — | ||
| Q1 24 | $242.0M | — |
| Q4 25 | 11.2% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 7.5% | — | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 7.1% | — |
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 3.87× | 6.67× | ||
| Q3 25 | 11.36× | — | ||
| Q2 25 | 11.63× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 11.40× | 20.20× | ||
| Q3 24 | 4.64× | — | ||
| Q2 24 | 9.15× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXC
| GIS Segment | $1.6B | 50% |
| CES Segment | $1.3B | 40% |
| Insurance Segment | $321.0M | 10% |
FMS
Segment breakdown not available.
